Welcome!

News Feed Item

Velocity Pharmaceutical Development Announces Appointment of Stuart Sedlack as Senior Vice President, Business Development

SOUTH SAN FRANCISCO, Calif., Jan. 7, 2014 /PRNewswire/ -- Velocity Pharmaceutical Development (VPD) today announced a key addition to the Company's management team with the appointment of Stuart Sedlack as Senior Vice President, Business Development.  The appointment rounds out VPD's executive leadership and will help drive the Company's corporate strategy.  Mr. Sedlack will report to David Collier, MD, VPD's Chief Executive Officer and Managing Director of CMEA Capital.

"I am delighted to welcome Stuart to the Velocity team," stated Dr. Collier. "Stuart's deep experience in partnering, corporate strategy, finance and pharmaceutical development make him an ideal addition to Velocity.  I greatly look forward to working with him."  At VPD, Mr. Sedlack will have primary responsibility for identifying and transacting business opportunities that help build Velocity's business while also partnering and monetizing compounds that have achieved clinical proof of concept.  

Mr. Sedlack joins VPD with a significant record of achievement sourcing, negotiating and managing partnerships in the life science industry.  Most recently, Stuart was Senior Vice President, Corporate Development at Amarin Pharmaceuticals and a part of the executive management team that refocused the company from central nervous system (CNS) to cardiovascular therapeutics and developed and launched the company's lead product in early 2013.  In addition to CNS and cardiovascular partnering activities, he was responsible for strategic and operational initiatives including building and managing a network of contract manufacturing relationships.

After five years in international banking, In 1993 Mr. Sedlack entered the pharmaceutical industry as Director, Technology Licensing at the University of Maryland Medical System's licensing office.  Then, in 1997, Stuart joined Elan Corp, PLC where for six years he was a key member of Elan's corporate investment and licensing group based in New York.  As Vice President, Corporate Development, Stuart sourced and negotiated a large number of transactions and co-managed a large biotech and specialty pharma investment fund.  After Elan, for several years Stuart was Global Head, Negotiations for Novartis' Infectious Disease business unit in Basel, Switzerland.  Stuart negotiated a number of transactions to help Novartis establish their presence in this field.  Returning to the US in 2006, Stuart joined Alba Therapeutics as Senior Vice President, Corporate Development and, after a relatively short period and following the out-licensing of the company's lead asset, joined Amarin in 2007.  

About Velocity Pharmaceutical Development, LLC

Velocity Pharmaceutical Development (VPD) is a pharmaceutical development organization dedicated to rapidly advancing promising drug candidates to clinical proof of concept using a highly virtual management model.  VPD seeks to acquire promising drug candidates, generally within a year of their entering human clinical trials or after initial human clinical data have been generated.  VPD then manages a highly virtual development program for each drug candidate intended to generate convincing human proof of concept data.  Following successful human proof of concept, VPD then seeks a large pharmaceutical company acquirer for each program.  VPD is staffed by a seasoned team of clinical drug developers with expertise in identifying attractive drug candidates, target markets, and designing and managing outsourced clinical trials. This expert team manages multiple single asset companies to remove the costly overhead and misaligned incentives present in traditional biotechnology company structures. VPD operates on a rapid decision principle, which identifies drug candidates with the greatest promise and repurposes capital from those that don't work out early in the process. VPD believes this new capital-efficient model will yield attractive new drugs to treat patients with significant unmet clinical needs. The company is located in South San Francisco, California.  More information is available at www.vpd.net.

Contact 
Leslie Loven
1-415-524-7326
[email protected]

SOURCE Velocity Pharmaceutical Development

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
Two weeks ago (November 3-5), I attended the Cloud Expo Silicon Valley as a speaker, where I presented on the security and privacy due diligence requirements for cloud solutions. Cloud security is a topical issue for every CIO, CISO, and technology buyer. Decision-makers are always looking for insights on how to mitigate the security risks of implementing and using cloud solutions. Based on the presentation topics covered at the conference, as well as the general discussions heard between sessio...
IoT is rapidly becoming mainstream as more and more investments are made into the platforms and technology. As this movement continues to expand and gain momentum it creates a massive wall of noise that can be difficult to sift through. Unfortunately, this inevitably makes IoT less approachable for people to get started with and can hamper efforts to integrate this key technology into your own portfolio. There are so many connected products already in place today with many hundreds more on the h...
Andi Mann, Chief Technology Advocate at Splunk, is an accomplished digital business executive with extensive global expertise as a strategist, technologist, innovator, marketer, and communicator. For over 30 years across five continents, he has built success with Fortune 500 corporations, vendors, governments, and as a leading research analyst and consultant.
No hype cycles or predictions of zillions of things here. IoT is big. You get it. You know your business and have great ideas for a business transformation strategy. What comes next? Time to make it happen. In his session at @ThingsExpo, Jay Mason, Associate Partner at M&S Consulting, presented a step-by-step plan to develop your technology implementation strategy. He discussed the evaluation of communication standards and IoT messaging protocols, data analytics considerations, edge-to-cloud tec...
Today we can collect lots and lots of performance data. We build beautiful dashboards and even have fancy query languages to access and transform the data. Still performance data is a secret language only a couple of people understand. The more business becomes digital the more stakeholders are interested in this data including how it relates to business. Some of these people have never used a monitoring tool before. They have a question on their mind like “How is my application doing” but no id...
Announcing Poland #DigitalTransformation Pavilion
Digital Transformation is much more than a buzzword. The radical shift to digital mechanisms for almost every process is evident across all industries and verticals. This is often especially true in financial services, where the legacy environment is many times unable to keep up with the rapidly shifting demands of the consumer. The constant pressure to provide complete, omnichannel delivery of customer-facing solutions to meet both regulatory and customer demands is putting enormous pressure on...
CloudEXPO | DXWorldEXPO are the world's most influential, independent events where Cloud Computing was coined and where technology buyers and vendors meet to experience and discuss the big picture of Digital Transformation and all of the strategies, tactics, and tools they need to realize their goals. Sponsors of DXWorldEXPO | CloudEXPO benefit from unmatched branding, profile building and lead generation opportunities.
DXWorldEXPO LLC announced today that All in Mobile, a mobile app development company from Poland, will exhibit at the 22nd International CloudEXPO | DXWorldEXPO. All In Mobile is a mobile app development company from Poland. Since 2014, they maintain passion for developing mobile applications for enterprises and startups worldwide.
In his Opening Keynote at 21st Cloud Expo, John Considine, General Manager of IBM Cloud Infrastructure, led attendees through the exciting evolution of the cloud. He looked at this major disruption from the perspective of technology, business models, and what this means for enterprises of all sizes. John Considine is General Manager of Cloud Infrastructure Services at IBM. In that role he is responsible for leading IBM’s public cloud infrastructure including strategy, development, and offering m...
For far too long technology teams have lived in siloes. Not only physical siloes, but cultural siloes pushed by competing objectives. This includes informational siloes where business users require one set of data and tech teams require different data. DevOps intends to bridge these gaps to make tech driven operations more aligned and efficient.
The best way to leverage your CloudEXPO | DXWorldEXPO presence as a sponsor and exhibitor is to plan your news announcements around our events. The press covering CloudEXPO | DXWorldEXPO will have access to these releases and will amplify your news announcements. More than two dozen Cloud companies either set deals at our shows or have announced their mergers and acquisitions at CloudEXPO. Product announcements during our show provide your company with the most reach through our targeted audienc...
Everything run by electricity will eventually be connected to the Internet. Get ahead of the Internet of Things revolution. In his session at @ThingsExpo, Akvelon expert and IoT industry leader Sergey Grebnov provided an educational dive into the world of managing your home, workplace and all the devices they contain with the power of machine-based AI and intelligent Bot services for a completely streamlined experience.
@DevOpsSummit at Cloud Expo, taking place November 12-13 in New York City, NY, is co-located with 22nd international CloudEXPO | first international DXWorldEXPO and will feature technical sessions from a rock star conference faculty and the leading industry players in the world.
DXWorldEXPO | CloudEXPO are the world's most influential, independent events where Cloud Computing was coined and where technology buyers and vendors meet to experience and discuss the big picture of Digital Transformation and all of the strategies, tactics, and tools they need to realize their goals. Sponsors of DXWorldEXPO | CloudEXPO benefit from unmatched branding, profile building and lead generation opportunities.